CD274 and neoplasm: PD1-41BB co-expressing TCR-Ts showed superior tumor cell killing compared to TCR-Ts without PD1-41BB in a tumor-mimicking in vitro situation of repeated T-cell challenge with 3D tumor cell spheroids expressing PRAME and PD-L1.